ProShare Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-14,285
Closed -$2.46M 2370
2021
Q3
$2.46M Buy
14,285
+1,470
+11% +$253K 0.01% 676
2021
Q2
$1.61M Buy
12,815
+3,447
+37% +$433K ﹤0.01% 798
2021
Q1
$1.27M Sell
9,368
-872
-9% -$118K ﹤0.01% 865
2020
Q4
$1.31M Sell
10,240
-313
-3% -$40K ﹤0.01% 774
2020
Q3
$1.19M Buy
10,553
+1,951
+23% +$220K 0.01% 677
2020
Q2
$820K Sell
8,602
-1,334
-13% -$127K ﹤0.01% 771
2020
Q1
$893K Sell
9,936
-7,647
-43% -$687K 0.01% 615
2019
Q4
$932K Sell
17,583
-1,848
-10% -$98K ﹤0.01% 818
2019
Q3
$768K Sell
19,431
-563
-3% -$22.3K ﹤0.01% 841
2019
Q2
$821K Sell
19,994
-2,297
-10% -$94.3K ﹤0.01% 835
2019
Q1
$1.04M Buy
22,291
+2,557
+13% +$119K 0.01% 742
2018
Q4
$859K Sell
19,734
-3,761
-16% -$164K 0.01% 753
2018
Q3
$1.35M Sell
23,495
-838
-3% -$48K 0.01% 703
2018
Q2
$1.18M Sell
24,333
-1,466
-6% -$71.2K 0.01% 769
2018
Q1
$1.01M Sell
25,799
-4,142
-14% -$162K 0.01% 811
2017
Q4
$1.27M Buy
29,941
+5,952
+25% +$253K 0.01% 752
2017
Q3
$895K Buy
23,989
+1,334
+6% +$49.8K 0.01% 766
2017
Q2
$688K Sell
22,655
-646
-3% -$19.6K 0.01% 844
2017
Q1
$617K Sell
23,301
-6,038
-21% -$160K 0.01% 935
2016
Q4
$749K Buy
29,339
+2,428
+9% +$62K 0.01% 901
2016
Q3
$974K Sell
26,911
-4,146
-13% -$150K 0.01% 687
2016
Q2
$1.06M Buy
31,057
+604
+2% +$20.5K 0.01% 698
2016
Q1
$804K Buy
30,453
+547
+2% +$14.4K 0.01% 791
2015
Q4
$1.46M Buy
29,906
+2,619
+10% +$128K 0.02% 608
2015
Q3
$679K Sell
27,287
-1,670
-6% -$41.6K 0.01% 823
2015
Q2
$916K Sell
28,957
-205
-0.7% -$6.49K 0.01% 818
2015
Q1
$1.11M Buy
29,162
+4,269
+17% +$162K 0.01% 795
2014
Q4
$970K Buy
+24,893
New +$970K 0.01% 871
2014
Q3
Sell
-8,017
Closed -$272K 2392
2014
Q2
$272K Buy
8,017
+827
+12% +$28.1K ﹤0.01% 1970
2014
Q1
$248K Buy
+7,190
New +$248K ﹤0.01% 2369